BioAge Labs
BIOAGE discovers and develops drugs to treat aging and associated diseases. The company's primary initiative, azelaprag, is an oral APJ agonist on track for Phase 2 trials in conjunction with tirzepatide to potentially become a groundbreaking treatment for obesity in the elderly.
Domain
bioagelabs.com
Country
United StatesIndustry
BiopharmaEmployees
51-100
Last Funding
$115.0M
Founded
2014
Tech Stack (8 technologies)
Frequently Asked Questions
What technologies does BioAge Labs use?+
BioAge Labs uses 8 technologies including core-js, GSAP, Firebase.
What industry is BioAge Labs in?+
BioAge Labs operates in the Biopharma industry.
Where is BioAge Labs based?+
BioAge Labs is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026